Kayudi Biotechnology (Beijing) Co., Ltd. is a domestic original research and high-tech innovative enterprise that has been deeply involved in the field of molecular diagnosis for more than ten years, and is especially good at the rapid detection technology of pathogenic microorganism nucleic acid. The company has the ability to jointly develop instruments, reagents, system platforms and artificial intelligence big data, and has independent patented core technologies. ?
Founded in 2009, the company has its headquarters and R&D center in Beijing, and subsidiaries in Beijing, Jiangsu, Tianjin and other places. As a national high-tech enterprise and academician expert workstation, it has successively won the honors of "Top 50 Enterprises with the Most Investment Value in China", "Most Potential Enterprise in China", "Advanced Group for Fighting COVID-19 Epidemic in 2020 commended by the Ministry of Industry and Information Technology" and "Science and Technology Entrepreneurship Contribution Award of China Science and Technology Entrepreneurship Association".
Introduction of Kayudi Company
Kayudi was established in 2009, and its core management and technical team members are from well-known universities at home and abroad, such as UCSD, Nottingham University, Peking University, Tsinghua University, Beijing Institute of Technology and China Agricultural University. Since its establishment, Kayudi has given priority to scientific research and undertaken many national and local projects. Through the practical experience of Ebola epidemic in Africa and Zika international epidemic, Kayudi has accumulated experience and technical reserves, and passed the product verification of authoritative scientific research institutions in many countries.
In 2020, in the face of the outbreak and spread of COVID-19 epidemic in many places around the world, Kayoudi successfully developed a series of products for rapid detection of nucleic acids in COVID-19 and a "Flash20 test" shelter with its own scientific research strength, which contributed its own scientific and technological strength to speeding up the detection efficiency in COVID-19. The vision of "let everyone benefit from molecular diagnosis" is the source of Kayoudi's continuous breakthrough in innovation and hard work. It is also a firm historical mission under the background of normalization of epidemic prevention and control, and it has become the only key enterprise in Wuxi.